(Q38750390)

6 September 2017

title

Inhibition of MRSA and of Clostridium difficile by durancin 61A: synergy with bacteriocins and antibiotics (English)

1 reference

6 September 2017

main subject

Clostridium difficile

0 references

0 references

2

1 reference

6 September 2017

7

1 reference

6 September 2017

Hasna Hanchi

1

1 reference

6 September 2017

Hélène Gingras

3

1 reference

6 September 2017

Rim Kourda

4

1 reference

6 September 2017

Michel G Bergeron

5

1 reference

6 September 2017

Jeannette Ben Hamida

6

1 reference

6 September 2017

Ismail Fliss

8

1 reference

6 September 2017

publication date

20 February 2017

1 reference

6 September 2017

number of pages

8

1 reference

based on heuristic

inferred from page(s)

published in

Future Microbiology

1 reference

6 September 2017

volume

12

1 reference

6 September 2017

page(s)

205-212

1 reference

Multidrug resistance in bacteria

6 September 2017

cites work

1 reference

https://api.crossref.org/works/10.2217%2FFMB-2016-0113

Strong synergy between a eukaryotic antimicrobial peptide and bacteriocins from lactic acid bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB-2016-0113

Anti-infective properties of bacteriocins: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB-2016-0113

Bacteriocins: developing innate immunity for food

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB-2016-0113

Ribosomally synthesized and post-translationally modified peptide natural products: overview and recommendations for a universal nomenclature

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB-2016-0113

Characterization of reutericyclin produced by Lactobacillus reuteri LTH2584

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB-2016-0113

Mechanism of bactericidal activity of microcin L in Escherichia coli and Salmonella enterica

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB-2016-0113

Efficacy of microcin J25 in biomatrices and in a mouse model of Salmonella infection

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB-2016-0113

Inactivating methicillin-resistant Staphylococcus aureus and other pathogens by use of bacteriocins OR-7 and E 50-52.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB-2016-0113

In vivo activity of mutacin B-Ny266.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB-2016-0113

Mersacidin eradicates methicillin-resistant Staphylococcus aureus (MRSA) in a mouse rhinitis model.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB-2016-0113

Antimicrobial activity of lacticin 3,147 against clinical Clostridium difficile strains.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB-2016-0113

The two peptide lantibiotic lacticin 3147 acts synergistically with polymyxin to inhibit Gram negative bacteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB-2016-0113

Nisin, alone and combined with peptidoglycan-modulating antibiotics: activity against methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB-2016-0113

Bacteriocinogenic properties and in vitro probiotic potential of enterococci from Tunisian dairy products

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB-2016-0113

Simultaneous Production of Formylated and Nonformylated Enterocins L50A and L50B as well as 61A, a New Glycosylated Durancin, by Enterococcus durans 61A, a Strain Isolated from Artisanal Fermented Milk in Tunisia

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB-2016-0113

Antibacterial activity evaluation of microcin J25 against diarrheagenic Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB-2016-0113

Inhibitory activity spectrum of reuterin produced by Lactobacillus reuteri against intestinal bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB-2016-0113

Enterococcus mundtii ST4SA and Lactobacillus plantarum 423 alleviated symptoms of Salmonella infection, as determined in Wistar rats challenged with Salmonella enterica serovar Typhimurium.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB-2016-0113

Characterization of a 3944 Da bacteriocin, produced by Enterococcus mundtii ST15, with activity against Gram-positive and Gram-negative bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB-2016-0113

Isolation and purification of enterocin E-760 with broad antimicrobial activity against gram-positive and gram-negative bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB-2016-0113

The effect of Reuterin on Listeria monocytogenes and Escherichia coli O157:H7 in milk and cottage cheese.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB-2016-0113

Combined effect of bacteriocins on the survival of various Listeria species in broth and meat system.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB-2016-0113

Antimicrobial resistance and virulence: a successful or deleterious association in the bacterial world?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB-2016-0113

The bacteriocin piscicolin 126 retains antilisterial activity in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB-2016-0113

21 January 2018

Identifiers

DOI

10.2217/FMB-2016-0113

1 reference

6 September 2017

1 reference